New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination.

Published in: Clinical case reports (2021)

The COVID-19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well-tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
respiratory syndrome coronavirus
prognostic factors
stress induced
patient reported